Home > About Us > CNIO News

CNIO News

Luis Paz-Ares has received the Lilly Foundation Award for Clinical Biomedical Research 2017

Madrid, 9 June, 2017

The Lilly Foundation Biomedical Research Awards 2017 ceremony was held yesterday. On this occasion, its 16th edition, the winners were Professors Luis Paz-Ares and Francisco Martínez Mojica, in the categories of Clinical and Preclinical Research, respectively. These awards recognize the scientific careers of researchers who contribute to the advancement of Biomedicine and the Health Sciences in Spain. The Secretary of State for Research, Development and Innovation, Carmen Vela, presided the...

Read more...
Manuel Valiente, jefe del Grupo de Metástasis Cerebral

Manuel Valiente receives funding from Melanoma Research Alliance

Madrid, 22 May, 2017

Manuel Valiente, head of the Brain Metastasis Group at the Spanish National Cancer Research Centre (CNIO), has been funded in the 2017 grant cycle by the Melanoma Research Alliance (MRA), the largest private funder of melanoma research. The research, titled ‘Blocking melanoma brain metastasis by targeting the microenvironment’, will focus on investigate actionable targets that will lead to more efficient design of anticancer treatments for patients with metastatic melanoma to the brain.MRA’s...

Read more...
Iván Plaza-Menacho

Ivan Plaza-Menacho has joined the CNIO to study the biophysics and the structure of proteins involved in cancer

Madrid, 18 May, 2017

Ivan Plaza-Menacho’s exceptional and multidisciplinary scientific approach, which combines experience in both structural biology and cancer cell biology, is coming to the Spanish National Cancer Research Centre (CNIO). The researcher will head the Kinases, Protein Phosphorylation, and Cancer Group, which focuses on studying the 3D structure of kinases, which are intimately involved in the origin and development of cancer, as well as in the resistance to chemotherapeutic drugs.  "The fact...

Read more...
CNIO & The City

‘CNIO and The City’: Building bridges with society

Madrid, 11 May, 2017

'CNIO and the City', a project which aims to strengthen ties between the Spanish National Cancer Research Centre (CNIO) and public educational centres in the Autonomous Community of Madrid has been one of the projects selected to receive funds from the Spanish Science and Technology Foundation (FECYT) to promote a culture of science, technology and innovation.The CNIO's teaching vocation is firm. Not only because nearly half of the research staff is in training but because of its links to...

Read more...
Logo CNIO

International meeting on proteins that could give rise to a new generation of cancer drugs

Madrid, 28 April, 2017

About 500 proteins involved in several types of cancer have already been identified; however, existing drugs can only act against 5% of them. A major part of research is therefore geared towards finding compounds that act against orphan proteins, whose active ingredients must, consequently, be innovative. This is key, say researchers, to design therapies that adapt to each patient’s type of cancer: the quest for personalised medicine, that is more effective and causes fewer side effects. A...

Read more...
Erwin Wagner, director del Programa de Biología Celular del Cáncer

A project that studies chronic systemic inflammation receives EU funding

Madrid, 10 April, 2017

Erwin Wagner, Director of the Cancer Cell Biology Programme at the Spanish National Cancer Research Centre (CNIO), has been awarded an Advanced Grant from the European Research Council (ERC) to study Chronic Systemic Inflammation, a major health problem that causes morbidity and mortality associated with pathologies of the immune system and cancer.“The aim of this research proposal is to substantially advance our understanding of whole-organism physiology in relation to systemic inflammation as...

Read more...
Firma acuerdo CNIO-PharmaMar

CNIO and PharmaMar have signed a collaboration agreement to identify new anti-tumour therapies

Madrid, 21 March, 2017

The Spanish National Cancer Research Centre (CNIO) and PharmaMar (MSE:PHM) have signed a collaboration agreement which consists in the implementation of new screening tests to characterise potential anti-tumour compounds of marine origin.This agreement was presented at a ceremony held at the CNIO headquarters in the presence of Dr María A. Blasco, CNIO Director; Ms Carmen Vela Olmo, Secretary of State for Research, Development and Innovation, and President of the Board of the CNIO; and Mr José...

Read more...
Una habitación propia

A play at a cancer research centre

Madrid, 1 March, 2017

The stage of the CNIO auditorium has hosted some of the world's most illustrious scientists. Nobel laureates, political leaders, cultural icons… However, on 7 March, the Spanish National Cancer Research Centre (CNIO) will become a theatre. On occasion of the International Women’s Day, and promoted by the centre's Women in Science and Engineering Office (WISE), a single performance of 'A Room of One's Own’, a stage adaptation of the work by Virginia Woolf, will be offered.In this work, Woolf...

Read more...
Primary and secondary brain tumors

World-renowed brain tumour experts gather at the CNIO

Madrid, 16 February, 2017

Brain tumours are going to be the key players at the upcoming CNIO-"La Caixa" Foundation Frontiers Meetings (CFM), which will bring together 130 experts from around the world to address, from a multidisciplinary perspective, all aspects related to this heterogeneous and complex pathology. The meeting will take place from 19 to 22 February in the auditorium of the Spanish National Cancer Research Centre (CNIO)."Primary and secondary brain tumours are an unmet clinical need," explains Manuel...

Read more...
ASISA Vida y Amigos del CNIO, unidos por la investigación del cáncer

ASISA Vida and 'CNIO Friends’ join forces for cancer research

Madrid, 30 January, 2017

The Spanish National Cancer Research Centre (CNIO) has signed a collaboration agreement with ASISA Vida linked to a new product launched by this company. It is an insurance policy for women, which includes specific coverage of gynaecological cancer. Thanks to the awareness the insurance company has for this issue, 5% of the premiums of ASISA Vida Mujer will be donated to the 'CNIO Friends’ initiative to fund cancer research.ASISA Vida has, therefore, become a member of the 'CNIO...

Read more...